FdaApplication
ANDA 206418
Identifiers
- fda_app_no: ANDA206418
Properties
| Property | Value |
|---|---|
| applicant_name | WEST-WARD PHARMS INT |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAPENTADOL | TAPENTADOL | 150MG | TABLET, EXTENDED RELEASE;ORAL |
| TAPENTADOL | TAPENTADOL | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| TAPENTADOL | TAPENTADOL | 200MG | TABLET, EXTENDED RELEASE;ORAL |
| TAPENTADOL | TAPENTADOL | 250MG | TABLET, EXTENDED RELEASE;ORAL |
4 products